4cgn: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "4cgn" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
The entry 4cgn is ON HOLD | The entry 4cgn is ON HOLD until Paper Publication | ||
Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J. | Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J. | ||
Description: Leishmania major N-myristoyltransferase in complex with a piperidinylindole inhibitor | Description: Leishmania major N-myristoyltransferase in complex with a piperidinylindole inhibitor | ||
Revision as of 08:49, 18 December 2013
Unreleased structure
The entry 4cgn is ON HOLD until Paper Publication
Authors: Brannigan, J.A., Roberts, S.M., Bell, A.S., Hutton, J.A., Smith, D.F., Tate, E.W., Leatherbarrow, R.J., Wilkinson, A.J.
Description: Leishmania major N-myristoyltransferase in complex with a piperidinylindole inhibitor
